Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Encapsulated Fecal Microbiota Transplantation in Peanut Allergic Patients
NCT02960074Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Jul 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of fecal microbiota capsule in peanut allergy. Started Mar 2017; status: completed.
02
Drugs
fecal microbiota capsule
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02960074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960074.